PSA Nitrogen Generator for Pharmaceutical Industry

PSA Nitrogen Generator for Pharmaceutical Industry – API Blanketing, Lyophilisation & GMP Compliance

Absstem provides advanced PSA nitrogen generators across India, engineered for the demanding purity, documentation, and regulatory compliance requirements of pharmaceutical manufacturing. Our systems deliver continuous, high-purity nitrogen for API (Active Pharmaceutical Ingredient) blanketing and inerting, lyophilisation (freeze-drying) support, aseptic packaging, tablet compression, purging, and cleanroom atmosphere maintenance – helping pharmaceutical manufacturers meet CGMP, WHO-GMP, Schedule M, and IP/USP standards.

From large continuous API manufacturing plants requiring 99.999% nitrogen purity to smaller research facilities and formulation units, Absstem’s nGEN and nGENX systems are sized to your exact requirement – IIoT-monitored* with continuous purity logging for GMP documentation, and backed by a 10-year Carbon Molecular Sieve warranty.

99.9 to 99.999% Purity

CGMP-Compatible

Up to 3,000 Nm³/hr

Flow Range

IIoT Remote Monitoring*

*T&C Apply

Schedule M

WHO-GMP Compatible

10-Year Sieve Warranty

Made in India

Benefits of Nitrogen

Every pharmaceutical manufacturer operates under the constant obligation to produce and supply safe, effective medicinal formulations in complete adherence to Current Good Manufacturing Practices (CGMP) – and in India, under Schedule M of the Drugs and Cosmetics Act (revised 2023). Handling hazardous chemicals and maintaining a clean, controlled, and documented manufacturing environment is non-negotiable in any pharmaceutical plant. Nitrogen is a critical utility in pharmaceutical manufacturing, acting as the primary inerting and blanketing agent to protect Active Pharmaceutical Ingredients (APIs) from oxidation and moisture during synthesis, processing, storage, and packaging. Nitrogen is also used for equipment purging between product changeovers, creating inert atmospheres in reactors handling flammable solvents, and supporting aseptic packaging lines for sterile products. On-site PSA nitrogen generation has become the standard for pharmaceutical manufacturers across India, replacing cylinder nitrogen supply that introduces handling risk, supply chain vulnerability, and per-Nm³ cost premiums. Critically, PSA nitrogen generators with IIoT monitoring* provide the continuous, documented purity record that CGMP and WHO-GMP guidelines require for nitrogen used in pharmaceutical applications.

How PSA Nitrogen Generators Support Pharmaceutical Manufacturing

Absstem provides high-quality PSA nitrogen generators across India, specially designed for the pharmaceutical industry. These generators ensure a consistent supply of high-purity nitrogen, helping maintain product safety, prevent contamination, and improve overall manufacturing efficiency. What distinguishes Absstem for pharmaceutical applications is IIoT remote monitoring* as an add-on facility – purity, pressure, and flow are tracked continuously and logged automatically. For CGMP-compliant facilities, this continuous purity log satisfies documentation requirements for nitrogen quality in drug manufacturing without manual sampling or third-party purity testing. The 10-year Carbon Molecular Sieve warranty reduces the long-term operating cost uncertainty that pharmaceutical QA managers must account for in their validation budgets.

Key Applications

API Blanketing & Process Inerting

Nitrogen blankets Active Pharmaceutical Ingredients (APIs) during synthesis, processing, storage, and transfer, preventing the oxidation and moisture uptake that degrade stability, potency, and purity. Reactors and vessels are kept under continuous nitrogen pressure throughout the reaction cycle. Between campaigns and product changeovers, the same nitrogen purges reactors, pipelines, and filling lines of residual product, solvent vapours, and moisture, supporting CGMP cross-contamination prevention before the next batch.

Aseptic Packaging & Container Inerting

Nitrogen is flushed into pharmaceutical packaging – vials, ampoules, blister packs, sachets, and bulk containers – before and during filling to displace oxygen and maintain sterility. This reduces oxygen-driven degradation, extends shelf life, and maintains product potency from manufacturing through to patient use. For sterile injectables and biologicals, nitrogen in the headspace of vials is a standard requirement under pharmacopoeia specifications.

Lyophilisation (Freeze-Drying) Support

Lyophilisation – freeze-drying of biologicals, vaccines, and sensitive APIs – requires nitrogen for chamber purging between cycles to remove residual moisture and oxygen before loading product, and for back-fill during vial stoppering at the end of the drying cycle. Nitrogen back-fill maintains an inert headspace inside the vial as it is stoppered – critical for biologicals that degrade in the presence of oxygen. PSA nitrogen at 99.99 to 99.999% purity is used for both chamber purging and vial back-fill in lyophilisation.

Solvent Handling, Recovery & Fire Prevention

Pharmaceutical manufacturing involves handling flammable organic solvents – ethanol, acetone, methanol, IPA – in synthesis, extraction, and chromatography. Nitrogen inerting of solvent storage tanks and process vessels keeps oxygen concentrations below the LOC (Limiting Oxygen Concentration), preventing explosive atmospheres from forming. This is a Schedule M and fire safety compliance requirement for pharmaceutical facilities handling flammable materials.

Tablet Compression, Granulation & Dry Room Inerting

Nitrogen is used in tablet compression and granulation areas to maintain low-humidity, oxygen-reduced environments for moisture-sensitive drug formulations. Nitrogen-purged dry rooms and compression booths protect API powders and granules from atmospheric moisture that can cause caking, degradation, and inconsistent tablet hardness. Continuous nitrogen supply is maintained throughout the compression shift to ensure consistent product quality.

Pharmaceutical nitrogen applications share LOC control and solvent handling principles with chemical manufacturing
Similar nitrogen blanketing and packaging applications are used in the food industry

Regulatory Compliance – CGMP, Schedule M & WHO-GMP

Standard / Body Relevance for Pharmaceutical Nitrogen Absstem Status
CGMP (Current Good Manufacturing Practices) Nitrogen quality documentation required for drug manufacturing IIoT continuous purity logs ✔
Schedule M – Drugs & Cosmetics Act India (revised 2023) India’s revised GMP standard – nitrogen purity in manufacturing Compatible ✔
WHO-GMP (WHO Technical Report Series) International GMP standard for pharmaceutical manufacturers Compatible ✔
Indian Pharmacopoeia (IP) Nitrogen purity specifications for drug manufacturing 99.99–99.999% compliant ✔
USP (US Pharmacopeia) – for export-oriented units International purity standard for US-export pharma 99.999% configurable ✔
21 CFR Part 11 (for US FDA-approved plants) Electronic records and purity documentation requirements IIoT logs support compliance ✔

Absstem’s IIoT monitoring* platform continuously logs nitrogen purity, pressure, and flow – providing the automatic, date-timestamped purity record that CGMP documentation requirements mandate for nitrogen used in drug manufacturing. This eliminates the need for manual purity sampling and third-party testing for routine operational documentation.

Challenges

Nitrogen
Need for Extremely High-Purity Nitrogen

Pharma applications typically need 99.99-99.999% nitrogen, among the highest purity requirements of any industrial gas use. Even trace oxygen (above 10-100 ppm) can degrade APIs, affect reaction yields, or compromise sterility. 

Oxidation
Risk of Oxidation Affecting Drug Stability

Many APIs are highly oxygen-sensitive. Even brief exposure during processing, transfer, or storage can cause potency loss, discolouration, or degradation products that fail pharmacopoeia specifications. Continuous nitrogen blanketing is the primary defence.

CGMP and regulatory requirements
Compliance with CGMP & Regulatory Requirements

Every nitrogen application must be documented and traceable under CGMP, with purity, pressure, and flow verified on an ongoing basis, not just at installation. IIoT monitoring* logs purity continuously, supporting CGMP documentation without manual sampling.

Technical Data

Application Purity (%) Typical Flow Pressure (Barg)
API Blanketing and Process Inerting 99.9 – 99.999 10 – 200 Nm³/hr 2 – 5
Lyophilisation (chamber purge & back-fill) 99.99 – 99.999 5 – 50 Nm³/hr 2 – 5
Aseptic Packaging & Container Inerting 99.99 5 – 50 Nm³/hr 2 – 5
Tablet Compression / Dry Room 99.5 – 99.9 5 – 50 Nm³/hr 2 – 5
Solvent Handling / LOC Control 99.9 – 99.99 10 – 100 Nm³/hr 2 – 5

On-Site PSA Nitrogen vs Cylinder Supply for Pharmaceutical Manufacturing

Factor Cylinder / LIN Nitrogen Absstem PSA (nGEN/nGENX)
Cost per Nm³ ₹600/- to ₹1000/- (Cylinders) / ₹15/- to ₹25/- (LIN) ₹1.80/- (95%) to ₹10.60/- (99.9995%)
Purity documentation for GMP Manual sampling, periodic testing IIoT continuous logs – automatic ✔
Supply continuity Delivery-dependent – batch risk 24/7 from atmospheric air
PESO storage licence Required for cylinder storage NOT required for PSA generator
Typical payback N/A – recurring cost forever 8–18 months

Calculate your pharma plant’s savings in 2 minutes

Trusted By Thousands

FAQs – Nitrogen Generators for Pharmaceutical Industry

PSA generators provide a continuous supply of 99.99 to 99.999% nitrogen for API blanketing, vessel inerting, lyophilisation, aseptic packaging, and equipment purging. IIoT monitoring* provides continuous purity documentation for CGMP compliance. This eliminates cylinder delivery dependency and reduces nitrogen costs by up to 80% versus cylinder supply.

Key advantages: (1) Cost reduction up to 80% vs cylinders. (2) Continuous supply – no delivery dependency or batch risk. (3) IIoT purity logging for automatic CGMP documentation. (4) No PESO cylinder storage licence required for the PSA generator. (5) Purity configurable at commissioning from 99.5% to 99.999% for different applications. (6) 10-year CMS warranty reduces long-term operating cost uncertainty.

High-purity nitrogen (99.99 to 99.999%) is required for: API blanketing and reactor inerting, lyophilisation (freeze-drying) chamber purging and vial back-fill, aseptic packaging for sterile injectables, and chromatography. Lower purity (99.5 to 99.9%) is used for tablet compression, dry room inerting, and equipment purging. Absstem’s nGEN is configured at commissioning to the exact purity required for each application.

PSA generators produce nitrogen on-site from atmospheric air at ₹1.80/- (95%) to ₹10.60/- (99.9995%) vs ₹600/- to ₹1000/- for cylinders. More importantly for pharma, PSA generators with IIoT monitoring* provide continuous, documented purity records for CGMP compliance – replacing periodic manual sampling. No delivery dependency eliminates the batch risk that cylinder supply introduces.

Yes. Absstem’s nGEN and nGENX systems are configured at commissioning to the exact purity, pressure, and flow required by your specific pharmaceutical applications. For large API plants, nGEN provides continuous, scalable nitrogen at up to 99.999%. For small formulation units, nGENX provides plug-and-play nitrogen with the same IIoT monitoring and GMP documentation capability.

Absstem’s PSA nitrogen generators deliver 99.99 to 99.999% purity nitrogen compatible with CGMP, Schedule M (revised 2023), WHO-GMP, Indian Pharmacopoeia, and USP requirements for nitrogen in pharmaceutical manufacturing. The IIoT monitoring* system provides continuous, timestamped purity logs – satisfying CGMP’s documentation requirement for nitrogen quality without manual sampling. IQ/OQ/PQ validation documentation is available on request.

Lyophilisation requires 99.99 to 99.999% nitrogen purity for chamber purging (removing residual moisture and oxygen before loading product) and vial back-fill during stoppering (maintaining an inert headspace in the vial as it is sealed). For biologicals, vaccines, and oxygen-sensitive APIs, any oxygen contamination during the back-fill step can degrade product stability and potency. Absstem’s nGEN delivers consistent 99.999% purity with IIoT verification throughout the lyophilisation cycle.

nGEN is suited for large API manufacturing plants and continuous pharmaceutical production above 100 Nm³/hr. nGENX is suited for small formulation units, research facilities, pilot plants, and pharmaceutical SMEs needing up to 100 Nm³/hr with fast, plug-and-play installation. Both include IIoT monitoring* with continuous purity logging for CGMP documentation, and the 10-year CMS warranty.

nGENX systems for small pharma formulation units (up to 100 Nm³/hr) typically range from ₹8 to 20 lakh. nGEN systems for large API plants range from ₹20 to 70+ lakh. Most pharmaceutical manufacturers achieve payback in 8 to 18 months through nitrogen cost savings. Contact Absstem for a requirement-specific quote: 1800 547 0506 | info@absstem.com | absstem.com/calculators/

Blogs

Discuss Your Nitrogen Requirement

For further information and tailored solutions, please contact us.


ROI Calculator
×

Scroll to Top